McIlhenny, EH; Pipkin, KE; Standish, LJ; Wechkin, HA; Strassman, R; Barker, SA. Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography–electrospray ionization-tandem mass spectrometry. J. Chromatogr. A, 18 Dec 2009, 1216 (51), 8960–8968. 450 kB. https://doi.org/10.1016/j.chroma.2009.10.088 LC,MS
McIlhenny, EH; Riba, J; Barbanoj, MJ; Strassman, R; Barker, SA. Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine. Biomed. Chromatogr., 1 Sep 2011, 25 (9), 970–984. 1.0 MB. https://doi.org/10.1002/bmc.1551 #11
McIlhenny, EH; Riba, J; Barbanoj, MJ; Strassman, R; Barker, SA. Methodology for determining major constituents of ayahuasca and their metabolites in blood. Biomed. Chromatogr., 1 Mar 2012, 26 (3), 301–313. 557 kB. https://doi.org/10.1002/bmc.1657
Barker, SA; Borjigin, J; Lomnicka, I; Strassman, R. LC/MS/MS analysis of the endogenous dimethyltryptamine hallucinogens, their precursors, and major metabolites in rat pineal gland microdialysate. Biomed. Chromatogr., 1 Dec 2013, 27 (12), 1690-1700. 929 kB. https://doi.org/10.1002/bmc.2981
Buchanan, MS; Carroll, AR; Pass, D; Quinn, RJ. NMR spectral assignments of a new chlorotryptamine alkaloid and its analogues from Acacia confusa. Magn. Reson. Chem., 1 Apr 2007, 45 (4), 359-361. 103 kB. https://doi.org/10.1002/mrc.1959 #4 MS,NMR
Barker, SA. N,N-dimethyltryptamine (DMT), an endogenous hallucinogen: Past, present, and future research to determine its role and function. Front. Neurosci., 6 Aug 2018, 12 (536). 1.0 MB. https://doi.org/10.3389/fnins.2018.00536 #DMT N-oxide
Qu, S; Wang, G; Duan, W; Yao, S; Zuo, J; Tan, C; Zhu, D. Tryptamine derivatives as novel non-nucleosidic inhibitors against hepatitis B virus. Bioorg. Med. Chem., 15 May 2011, 19 (10), 3120–3127. 692 kB. https://doi.org/10.1016/j.bmc.2011.04.004 #3a MS,NMR
Sherwood, AM; Claveau, R; Lancelotta, R; Kaylo, KW; Lenoch, K. Synthesis and characterization of 5-MeO-DMT succinate for clinical use. ACS Omega, 15 Dec 2020, 5 (49), 32067–32075. 3.2 MB. https://doi.org/10.1021/acsomega.0c05099 #21 MS,NMR
5-MeO-AMT · 5-MeO-α-MT · 5-Methoxy-α-methyltryptamine · Alpha-O · α,O-DMS
4-HO-DMT · 4-Hydroxy-N,N-dimethyltryptamine · CX-59 · PAL-153 · PSOH · Psilocin
5-HO-DMT · 5-Hydroxy-N,N-dimethyltryptamine · Bufotenin
5-MeO-NMT · 5-Methoxy-N-methyltryptamine · N,O-DMS · nor-5-MeO-DMT
6-HO-DMT · 6-Hydroxy-N,N-dimethyltryptamine · 6-Hydroxy-DMT
7-MeO-NMT · 7-Methoxy-N-methyltryptamine
4-MeO-NMT · 4-Methoxy-N-methyltryptamine
7-HO-DMT · 7-Hydroxy-N,N-dimethyltryptamine
4-HO-iso-DMT · 4-Hydroxy-N,N-dimethyl-isotryptamine
4-MeO-AMT · 4-Methoxy-α-methyltryptamine
6-MeO-AMT · 6-Methoxy-α-methyltryptamine
5-EtO-T · 5-Ethoxytryptamine
2,O-DMS · 2-Methyl-5-MeO-T · 2-Methyl-5-methoxytryptamine
1-Methyl-5-MeO-T · 1-Methyl-5-methoxytryptamine
7-Methyl-5-MeO-T · 7-Methyl-5-methoxytryptamine
4-HO-AET · 4-Hydroxy-α-ethyltryptamine
7-HO-NET · 7-Hydroxy-N-ethyltryptamine